Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q16795 (
ubiquinone
)
5,455
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Effect of cycloheximide, ethidium bromide and hydroxytetracycline on incorporation of label from I-14C-acetate into
ubiquinone
and cholesterol as well as from diffusively labelled 14C-tyrosine into
ubiquinone
was studied in slices of rat
hypertrophic kidney
within 2 days after unilateral nephrectomy. Incorporation of these labels into
ubiquinone
and of 1-14C-acetate into cholesterol was distinctly increased using slices of
hypertrophic kidney
. Repeated administration of cycloheximide just after the operation and within 24 hrs after it depressed the
kidney hypertrophy
, inhibited completely the label incorporation into cholesterol and partially - into
ubiquinone
. This suggests that the rate of enzymes production, responsible for synthesis of these substances, is increased in
hypertrophic kidney
. Injection of ethidium bromide after the operation inhibited distinctly the label incorporation into
ubiquinone
and did not effect on incorporation of 1-14C-acetate into cholesterol. Hydroxytetracycline proved to be ineffective in these labels incorporation. Mitochondrial DNA appears to participate in coding of some functionally active proteins responsible for
ubiquinone
biosynthesis.
...
PMID:[Activation of the incorporation of labeled precursors into ubiquinone in slices of rat hypertrophied kidney]. 66 87